Back to Isotope Catalog
R-11043

Erlotinib.HCl (13C6)

Stable isotope standard for analytical research and method development.

Module Type
Stable Isotope Standards
Category
Drugs & TDM
CAS
1210610-07-3
Unlabeled CAS
183319-69-9
PubChem CID
49849306
Molecular Formula
C16[13C]6H24ClN3O4
Molecular Weight
435.9
AI Isotope Property & Application AnalysisShow

Isotope Summary

Labels
13C6
Labeled atoms
6
Isotope positions
Confirmed in structure
Calculation reliability
High, based on explicit isotope structure

Mass & MS Parameters

Unlabeled exact mass
429.145534 Da
Labeled exact mass
435.165663 Da
Exact mass shift
6.020129 Da
Nominal mass shift
6
Ionm/zStatus
[M+H]+436.172939Theoretical
[M+Na]+458.154881Theoretical
[M+NH4]+453.199486Theoretical
[M-H]-434.158387Theoretical

Label Stability

Overall
Low risk
Calculation reliability
Medium, some information should be confirmed
  • Skeleton-bound 13C/15N labels are generally non-exchangeable under normal analytical handling.

Internal Standard Suitability

Rating
High
Chromatographic similarity
Expected high similarity
Natural isotope overlap
Low
  • Exact mass separation is 6.020129 Da; MS channel separation should be verified in the final method.
  • The unlabeled parent mass was derived from the isotope structure because a curated parent structure was not matched.
  • Overall suitability: High.

Recommended Applications

LC-MS/MS Quantitative Internal Standard
Recommended

LC-MS/MS Quantitative Internal Standard is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

Isotope Dilution Mass Spectrometry
Recommended

Isotope Dilution Mass Spectrometry is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

Metabolic Tracing
Not primary

Metabolic Tracing is classified as Not primary based on isotope mapping, mass separation, and label-stability rules.

Clinical Mass Spectrometry
Possible

Clinical Mass Spectrometry is classified as Possible based on isotope mapping, mass separation, and label-stability rules.

Bioanalytical Method Development
Recommended

Bioanalytical Method Development is classified as Recommended based on isotope mapping, mass separation, and label-stability rules.

AI Interpretation

This analysis is based on isotope-aware structure data. The compound contains 13C6, with an exact mass shift of 6.020129 Da. Label stability is assessed as Low risk, and internal-standard suitability is High. These results support analytical method development and require experimental validation.

AI-assisted analytical guidance is intended for method-development support. Actual isotope stability, chromatographic behavior, fragmentation and MRM transitions should be experimentally validated.